Ocular drug delivery systems face significant challenges due to the physiological and anatomical
barriers of the eyes. Nanotechnology has emerged as a promising approach to overcome these limitations and
potentially improve ocular bioavailability and patient compliance. Lipid-based ultra-deformable vesicular system...
R. Thakur, Navneet Sharma, Kamal Shah et al.· Current pharmaceutical desig...· 0 citations
Overall, nanocarrier-assisted nose-to-brain drug delivery represents a transformative platform for the management of central nervous system disorders and has the potential to overcome the limitations of conventional drug delivery systems and improve therapeutic outcomes for a wide range of neurological diseases.
Alpana, H. Dewangan· Current Nanomedicine· 0 citations
INTRODUCTION
Breast cancer is the most common cancer that affects women globally, with several molecular subtypes defined by hormone and growth factor receptor expression. While advances in understanding the biology of these subtypes have led to targeted therapies, aggressive forms, particularly Triple-Negative Breast...
S. Sengupta, Ruhi Arisha, Kamal Shah et al.· Recent Patents on Anti-Cance...· 0 citations
In-vivo studies showed a reduction in tumor volume, increased accumulation of the drug in the brain, and enhanced antioxidant enzyme levels, with favorable pharmacokinetics, indicating that the nanoparticles are a promising system for the management of glioblastoma.
H. Dewangan, N. Garg, Bharat Bhushan et al.· Journal of Pharmaceutical In...· 0 citations
Collectively, the advances are an indication of a transition to the personalized, mechanism-driven treatment strategies that would prolong the survivability of patients with advanced thyroid cancer, conquer resistance, and reduce systemic toxicity.
Tanmoy Sarkar, Ruhi Arisha, S. Sengupta et al.· Clinical and Translational O...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.